High-throughput screening of anti-lipidemic agents using PXB-cells®, human primary hepatocytes from humanized mice livers: Assessment of lipoproteins by an enzyme-linked immunosolvent assay on apolipoproteins

DOI Web Site Web Site

Bibliographic Information

Other Title
  • High-throughput screening of anti-lipidemic agents using PXB-cells, human primary hepatocytes from humanized mice livers : Assessment of lipoproteins by an enzyme-linked immunosolvent assay on apolipoproteins
  • Apolipoprotein assay for assessing lipoprotein in hepatocyte

Search this article

Description

We previously assessed anti-lipidemic activity by evaluating lipoprotein profiles in PXB-cells®, human primary hepatocytes from humanized mice livers, using LipoSEARCH®. This highly sensitive assay system detects low levels of extracellular lipoproteins; however, an increased throughput is needed to simultaneously assay multiple analytes. We herein investigated whether an enzyme-linked immunosolvent assay (ELISA) on apolipoproteins (APO) accurately detects reductions in extracellular lipoprotein levels in PXB-cells treated with fenofibrate as an alternative to LipoSEARCH. These results suggest the applicability of ELISA on APO to the conventional screening of anti-lipidemic activities in a large number of candidates.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top